BIOCHIPS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Biochips in US$ Million by the following Product Segments: DNA Chips, Protein Chips, and Lab Chips. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. The report profiles 76 companies including many key and niche players such as -

Affymetrix Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Caliper Life Sciences, Inc.
Cepheid Inc.
Fluidigm Corporation


Click here to request a full list of companies covered in the report...

Code : MCP-1026
Price : $4500
Companies : 76
Pages : 609
Date : March 2012
Market Data Tables : 47

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
A. DNA Chips.....I-3
B. Protein Chips.....I-3
  
   C. Lab Chips.....I-4  
   A Primer.....II-1
Recession Dries Up Funds for Biotech Firms.....II-1
1$100
   Promising Biochips Promote Biological Research.....II-2
Key Forces Driving the Industry.....II-2
1$100
   DNA Chips Lead the Application Front.....II-3
Protein Biochips – Set for Robust Expansion.....II-3
1$100
   Lab-on-a-Chips: Fusion of Nanotechnology & Genetic Engineering.....II-4
Industry Challenges.....II-4
Standardization: A Key Challenge.....II-4
1$100
   Price Dearness Pauses Biochips Growth.....II-51$100
   Current Approaches to Biochips.....II-6
The Business of Biochips.....II-6
1$100
   Technological Differentiation in Demand.....II-7
Focus on Highly Intelligent Diagnostic Systems.....II-7
Scalability & Pricing – Focus Areas.....II-7
Biochips: Expanding Role in Diagnostic Medicine.....II-7
1$100
   Advancements in Biochip Technology.....II-8
Biochip Technology Boosts Personalised Medicine.....II-8
1$100
   Biochip Technology Spreads beyond Pharma Industry.....II-9
Proteomics “Chip” into Biochip Technology.....II-9
1$100
   Towards Increasing Minaturization.....II-10
Technological Trends.....II-10
Sensitivity.....II-10
Microfabrication.....II-10
Density.....II-10
Integrated Chips.....II-10
1$100
   Patent Trends.....II-11
Table 1: Number of Lab-on-a-Chip Patents (includes corresponding Graph/Chart).....II-11

Table 2: % of Lab-on-a-Chip Patent Documents by Country/Authority of Origin (January 2008 – April 2009) (includes corresponding Graph/Chart).....II-11
1$350
   Table 3: Number of Lab-on-a-Chip Documents by Patent Assignees (January 2008 – April 2009) (includes corresponding Graph/Chart).....II-12
Patent Applications.....II-12
1$350
   Industry Structure.....II-13
Major Participants.....II-13
Affymetrix: A Major Market Player.....II-13
Growing Partnerships between Pharma and Biotech Companies.....II-13
1$100
   Tech Giants Join the Biochip Fray.....II-142$200
   Biochips – Complex Blend of Biochemistry and Electronics.....II-16
Historical Perspective.....II-16
2$125
   Lab-on-a-chip: An Enabled Technology.....II-18
Utility .....II-18
Evolution and Segmentation.....II-18
Differing Perspectives.....II-18
1$100
   Classification of Biochips.....II-191$100
   Need for Biochips.....II-20
Manufacturing Systems Used in Biochip Manufacture.....II-20
1$100
   Working of a Biochip.....II-21
DNA Transcription & Translation Through A Biochip.....II-21
A Functional Model.....II-21
Cocktail of Disparate Technically Specialized Applications.....II-21
Biochips: By-product of Multi-disciplinary Sciences.....II-21
1$100
   Nanotechnology.....II-22
BioMEMS.....II-22
1$100
   Microfluidics.....II-23
Micro Total Analysis System.....II-23
2$125
   Chip Architecture.....II-25
Essence of a Biochip.....II-25
Concept of a Microarray.....II-25
Microarray Modules.....II-25
1$100
   High Degree of Automation Spurs Biochips Use.....II-26
Microfabrication Technology in Biochips made from Polymer and Plastics.....II-26
Micro-optics in Biochips.....II-26
1$100
   Liquid Handling Through Micro-Dispensers.....II-27
Capillary Electrophoresis and Electrochemical Detectors.....II-27
Other Technologies.....II-27
Management of Bio-information.....II-27
1$100
   Scanning.....II-28
Microarray Database Management.....II-28
Classification of DNA Chips.....II-28
General Description of Spotted cDNA Microarrays.....II-28
Spotted DNA Arrays.....II-28
1$100
   Spotted cDNA Versus Spotted Oligonucleotide Arrays.....II-29
Limitations of Conventional cDNA Microarrays.....II-29
Protein Biochips.....II-29
1$100
   General Applications of Protein Biochips.....II-30
Challenges in the Design of a Protein Biochip.....II-30
1$100
   Limitations of Protein Chip Technology.....II-31
Concluding Remarks for Protein Biochips.....II-31
2$125
   Biochip Uses.....II-331$100
   Pharmaceutical Investigation.....II-34
Medical Diagnostics.....II-34
1$100
   Advantages of Biosensor Chip Technology.....II-35
Forensics.....II-35
Transplantation Screening.....II-35
Identity Testing.....II-35
Water and Environmental Testing.....II-35
Food Industry.....II-35
1$100
   Randox Launches Evidence Evolution Analyzer.....II-36
South Korea Develops Instant Microfluidic Biochip.....II-36
Fluidigm Introduces Reusable FR48.48 Dynamic Array™ IFC.....II-36
Cellix Introduces Vena4Y™ and Vena4Y2™ Biochips.....II-36
1$100
   Agilent Technologies Unveils Workflow HPLC-Chip.....II-37
Febit Holding Introduces First Human Cancer Biochip.....II-37
1$100
   Blue4Green Rolls Out Lab-on-a-chip Solution.....II-38
Randox Laboratories Unveils Biochip Arrays.....II-38
Randox Laboratories Introduces Evidence Investigator.....II-38
Randox Unveils Innovative DoA Biochips for Rapid Drug Screening.....II-38
1$100
   Randox Launches Revolutionary Biochip Analyser for Multiple Cardiac Testing.....II-39
Febit Unveils Biochip for DNA/RNA Detection and Enrichment on Mouse Genome.....II-39
Veredus Laboratories Launches Portable Test Kit for H1N1 Flu.....II-39
1$100
   Randox Develops Multi Marker Cardiac Biochip Array for MI Diagnosis.....II-40
VigeneTech and CapitalBio Launch Completely Integrated Microarray Solution
  Platform.....II-40
1$100
   Randox Introduces New Biochip Array for CAMs Testing.....II-41
Cellix Announces Global Launch of VenaEC Biochip.....II-41
Decision Biomarkers Rolls Out AVANTRA™ Biomarker Workstation System.....II-41
1$100
   Osaka Develops Biocompatible Monomers for Biochips.....II-42
Iris BioTechnologies Launches New Nano-Biochip.....II-42
Affymetrix Introduces Complete Cytogenetic Solution.....II-42
Agilent Unveils 244K CGH Micro-Array.....II-42
1$100
   Randox Unveils World’s First Protein Biochip.....II-43
Randox Introduces Thyroid Array Biochip.....II-43
Sigma Launches ChIP Kit.....II-43
1$100
   Randox Develops Biochip for Synthetic Steroids.....II-44
US and Czech Scientists to Develop Biochips for Detecting Cancer.....II-44
Manchester University Researchers Develop New Protein Chips Manufacturing
  Procedure.....II-44
1$100
   febit Introduces New Geniom Biochip.....II-45
Agilent Introduces Additions to the HPLC-Chip Line for Proteomics.....II-45
1$100
   Progenika Develops BLOODchip.....II-46
Roche Introduces Gene Expression Services and Arrays.....II-46
Stratos Biosystems Develops New EC-Affinity Biochips.....II-46
1$100
   Affymetrix Unveils Affymetrix GeneChip Command Console Software.....II-47
Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays.....II-47
Affymetrix Unveils Genome-Wide Human SNP Array 6.0.....II-47
1$100
   Caliper Life Sciences Launches High Throughput RNA Assay.....II-48
Applied Biosystems Unveils DNA Tools.....II-48
febit Launches Geniom RT Analyzer.....II-48
1$100
   Austrian Research Center Develops New Biochip Surface.....II-49
Researchers Develop Biochips to Eliminate Animal Testing.....II-49
Progenika Biopharma Launches IBD DNA.....II-49
1$100
   Bioident Develops New Lab-on-a-Chip Nanotiter Plate Prototype.....II-50
Ilochip and University of Denmark Develop a Biochip for Faster Bird Flu
  Detection.....II-50
CombiMatrix Develops a Biochip for Leukemia Analysis.....II-50
Affymetrix Launches New Tiling Arrays for Mapping Whole-Genome Transcript.....II-50
1$100
   Roche Plans to Launch AmpliChip in Japan.....II-51
Caliper Life Sciences Unveils Desktop Profiler.....II-51
Massachusetts Institute of Technology Develops Portable Lab on a Chip.....II-51
Optical Device to Develop Lab-on-a-Chip.....II-51
1$100
   Agilent Launches Five New HPLC Chips.....II-52
Protagen AG Launches New Protein Biochips.....II-52
Fluidigm Releases the 8.96 TOPAZ Screening Chip.....II-52
Affymetrix Releases Chip-on-Chip Array.....II-52
DNA Chip Research Launches High Sensitivity DNA Chip.....II-52
DNA Chip Research and HitachiSoft Unveils AceGene.....II-52
1$100
   PerkinElmer Acquires Caliper Life Sciences.....II-53
Philips and bioMerieux to Produce Biochips for Cardiovascular Assays.....II-53
Roche Diagnostics and CapitalBio to Sign MOU.....II-53
1$100
   SVTC Partners with TSMC to Commercialize New Technologies.....II-54
HORIBA Jobin Yvon Takes Over GenOptics.....II-54
GWC Technologies to Receive $100,000 Federal Grant.....II-54
1$100
   febit to Receive Funds for Biomarker Project.....II-55
Researchers Assess TB-Biochip MDR Test System.....II-55
IBM to Use DNA Chip for Developing Personalized Medicine.....II-55
1$100
   Invitrogen and Applied Biosystems Merge to Form Life Technologies Corporation.....II-56
China Medical Technologies Signs Agreement with Molecular Diagnostics
  Technologies.....II-56
DNA Chip Acquires HuBit’s Gene Analysis Business.....II-56
1$100
   Affymetrix Acquires USB.....II-57
Roche NimbleGen Forms Alliance with BioDiscovery to Provide CGH Solutions.....II-57
Illumina Announces Partnership with Genpathway for ChIP Sequencing Services.....II-57
1$100
   Jiangsu and IMDi Diagnosis to Establish Joint Venture.....II-58
Plexera Biosciences Enters into an Option Deal with Auguron.....II-58
Affymetrix and Avesthagen Enter into an Agreement.....II-58
1$100
   Roche NimbleGen and Affymetrix Announce Expansion of License Agreement.....II-59
Proteomika and Auguron Biosciences Ink Option Agreement.....II-59
1$100
   Gentel Biosciences and Eppendorf Enter into Global License Agreement.....II-60
GATC Biotech Establishes New Subsidiary.....II-60
Procognia Spins off Sense Proteomic.....II-60
Johns Hopkins University Purchases MassARRAY System.....II-60
1$100
   Yale University Purchases MassARRAY System.....II-61
Korea’s NIH Extends KARE Project with Affymetrix Technology.....II-61
febit Obtains US Patent for Hybselect, a Microfluidic Extraction Method.....II-61
1$100
   Atotech Enters into Research Collaboration with University of Albany.....II-62
CapitalBio and Beijing National Engineering Research Center Develop New Biochip
  Testing System.....II-62
Roche Takes Over NimbleGen.....II-62
1$100
   GenTel BioSciences Acquires Protein Chip Platform Assets of GSK.....II-63
Advanced Liquid Logic Acquires Nanolytics.....II-63
Applied Microarrays Acquires Select GE Healthcare’s Assets.....II-63
1$100
   Canon, Toshiba and Other Companies to Join Hands for Biochips.....II-64
BioChip Innovations Signs Research Collaboration Agreement with IME.....II-64
1$100
   Protagen Enters into a Partnership to Develop Antibodies.....II-65
Spanish Society of Rheumatology Enters into Collaboration with Progenika.....II-65
Affymetrix and Partners Healthcare Extend Collaboration.....II-65
1$100
   Agencourt, NuGEN and Affymetrix Clinical Services Collaborate.....II-66
Affymetrix Inks Licensing Agreement with Empire Genomics.....II-66
Caliper Enters into a Licensing Agreement with Monogram Biosciences.....II-66
1$100
   Affymetrix and IPSOGEN Sign Agreement.....II-67
bioMérieux and NuGEN Enter into Supply and Cross-License Agreement.....II-67
1$100
   VWR and CapitalBio Enter into a Distribution Agreement.....II-68
C3B Bags Contract from Department of Defense to Develop an Implantable Biochip.....II-68
UCL Subsidiary and Roche Diagnostics Ink Licensing Deal.....II-68
Affymetrix Establishes the European Cytogenetic Research Initiative.....II-68
1$100
   Fluidigm Establishes New Development Center.....II-69
Daiichi Pure Chemicals Applies for Approval to Market DNA Micro-array.....II-69
1$100
   GE Healthcare Snaps Up Biacore.....II-70
Bio-Rad Acquires Ciphergen’s Life Science Research Business.....II-70
Sysmex to Form Partnership with Affymetrix.....II-70
Daiichi, Toshiba Hokuto and Toshiba Join Hands.....II-70
1$100
   Affymetrix Collaborates with Zhejiang California Nanosystem Institute.....II-71
Merck Sharp & Dohme and Shanghai Biochip Enter into Co- operation Agreement.....II-71
Toshiba Signs Licensing Agreement with Antara BioSciences.....II-71
1$100
   MUSC Signs LOI with Lumera.....II-72
AVIVA Inks Agreement with Japan’s Cosmo Bio.....II-72
Lumera Signs Collaborative Agreement with Harvard Medical School.....II-72
1$100
   Whatman Receives CE Mark for CombiChip.....II-73
IDIBAPS Led Project Receives Approval from European Union.....II-73
Toray to Establish DNA Chip Business.....II-73
Protagen Forays into the US Market.....II-73
1$100
   Biacore Expands Operations into Chinese Market.....II-74
Nisshinbo to Replace Glass with Resin in DNA Production.....II-74
1$100
   Affymetrix Inc (US).....II-75
Agilent Technologies, Inc. (US).....II-75
Bio-Rad Laboratories, Inc. (US).....II-75
1$100
   Caliper Life Sciences, Inc. (US).....II-76
Cepheid Inc. (US).....II-76
1$100
   Fluidigm Corporation (US).....II-77
GE Healthcare Ltd. (UK).....II-77
Illumina, Inc. (US).....II-77
Life Technologies Corporation (US).....II-77
1$100
   Ocimum Biosolutions Ltd. (India).....II-78
Takara Bio, Inc. (Japan).....II-78
1$100
   Clontech Laboratories, Inc. (US).....II-79
Zyomyx, Inc. (US).....II-79
1$100
   Table 4: World Recent Past, Current & Future Analysis for Biochips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-801$350
   Table 5: World Historic Review for Biochips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-811$350
   Table 6: World 15-Year Perspective for Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-821$350
   Table 7: World Recent Past, Current & Future Analysis for DNA Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-831$350
   Table 8: World Historic Review for DNA Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-841$350
   Table 9: World 15-Year Perspective for DNA Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-851$350
   Table 10: World Recent Past, Current & Future Analysis for Protein Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-861$350
   Table 11: World Historic Review for Protein Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-871$350
   Table 12: World 15-Year Perspective for Protein Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-881$350
   Table 13: World Recent Past, Current & Future Analysis for Lab Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-891$350
   Table 14: World Historic Review for Lab Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-901$350
   Table 15: World 15-Year Perspective for Lab Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....II-911$350
   A. Market Analysis.....III-1
An Insight into Biochip Products & Services Market.....III-1
Rapid Growth for Protein, Lab Biochips.....III-1
1$75
   Robust Demand for Biochip Reagents and Consumables.....III-2
Growth Prospects for Biochip Instruments & Software.....III-2
Potential for Biochip Service Revenues.....III-2
Biochip Product & Service Demand Among Biotech Companies.....III-2
1$75
   Biochip Products and Services Demand in Life Science Research Applications.....III-3
Laboratory Chips Market.....III-3
1$75
   Table 16: US Laboratory Chip Market by Application (2007 & 2015P): Percentage Share Breakdown of Revenues for Life Science Research, Forensic Medicine, In Vitro Diagnostic Testing, Drugs-of- Abuse Testing, Disease Management, and Others (includes corresponding Graph/Chart).....III-4
Competitive Landscape.....III-4
1$200
   Table 17: Leading Players in the US Biochip Products and Services Market (2007): Percentage Share Breakdown of Revenues for Illumina, Affymetrix, Applied Biosystems, GE/Amersham, Invitrogen, Bio-Rad, Caliper Life Science, Cepheid, Agilent Techs, Beckman Coulter, and Others (includes corresponding Graph/Chart).....III-51$200
   B. Market Analytics.....III-6
Table 18: US Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-6
1$200
   Table 19: US Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-71$200
   Table 20: US 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-81$200
   Market Analytics.....III-9
Table 21: Canadian Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-9
1$200
   Table 22: Canadian Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-101$200
   Table 23: Canadian 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-111$200
   A. Market Analysis.....III-12
ICAN™ Technology for Large-Scale Production of DNA Fragments.....III-12
1$75
   B. Market Analytics.....III-13
Table 24: Japanese Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-13
1$200
   Table 25: Japanese Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-141$200
   Table 26: Japanese 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-151$200
   A. Market Analysis.....III-16
Lab-on-chip Market in Europe.....III-16
1$75
   European Advancements Shape Diagnostic Procedures.....III-17
B. Market Analytics.....III-17
Table 27: European Recent Past, Current & Future Analysis for Biochips by Geographic Region – France, Germany, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-17
1$200
   Table 28: European Historic Review for Biochips by Geographic Region – France, Germany, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-181$200
   Table 29: European 15-Year Perspective for Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, and Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-191$200
   Table 30: European Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-201$200
   Table 31: European Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-211$200
   Table 32: European 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-221$200
   Market Analytics.....III-23
Table 33: French Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-23
1$200
   Table 34: French Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-241$200
   Table 35: French 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-251$200
   A. Market Analysis.....III-26
Berlin, Brandenburg and Biochips.....III-26
1$75
   B. Market Analytics.....III-27
Table 36: German Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-27
1$200
   Table 37: German Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-281$200
   Table 38: German 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-291$200
   Market Analytics.....III-30
Table 39: UK Recent Past, Current & Future Analysis for Biochips by Product Segments – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-30
1$200
   Table 40: UK Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-311$200
   Table 41: UK 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-321$200
   Market Analysis.....III-33
Table 42: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-33
1$200
   Table 43: Rest of Europe Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-341$200
   Table 44: Rest of Europe 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-351$200
   A. Market Analysis.....III-36
China.....III-36
Basic Environment and Commercial Development.....III-36
1$75
   Biochip Research Institutes.....III-37
Taiwan.....III-37
Taiwan Pursues Promise of Biochip Sector.....III-37
International Advantage Sought.....III-37
1$75
   B. Market Analytics.....III-38
Table 45: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....III-38
1$200
   Table 46: Rest of World Historic Review for Biochips by Product Segment - DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....III-391$200
   Table 47: Rest of World 15-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart).....III-401$200
  
Total Companies Profiled: 77 (including Divisions/Subsidiaries - 87)

Region/Country Players

The United States 40 Japan 14 Europe 25 France 4 Germany 8 The United Kingdom 4 Spain 1 Rest of Europe 8 Asia-Pacific (Excluding Japan) 8
Click here to request a full table of contents and more details on this project.